EUVIMEDEUVIMED entdecken
Crossref

Myeloid‐Derived Suppressor Cell–Derived Interferon‐β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development

Ke Rui, Zixiang Chen, Jun Liu, Wei Huang, Xiaomeng Wang, Fan Xiao, Yingbo Zhou, Xiaoqiu Dai, Yuan Tang, Mengna Zhao, Na Peng, Xiaoran Wang und 4 weitere

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Ke Rui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Interferon-beta, T Follicular Helper Cells, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Increasing evidence highlights a critical role of T follicular helper (Tfh) cells in autoimmune pathogenesis. This study aimed to identify inflammatory cytokines involved in driving Tfh cell responses in systemic lupus erythematosus (SLE).

Methods

The circulating Tfh frequencies and interferon (IFN)‐β levels were analyzed for correlations with disease activities in patients with SLE. Both lupus mice with IFN‐β treatment and Ifnar1 −/− mice with lupus induction were assessed for Tfh cell responses and disease progression. Sorting‐purified naive CD4 + T cells from Ifnar1 −/− mice were adoptively transferred to lupus mice for monitoring Tfh cell differentiation in vivo. In culture, mouse CD4 + T cells treated with IFN‐β were examined for Tfh cell differentiation and intracellular signaling pathway. The underlying mechanism for IFN‐β secretion by myeloid‐derived suppressor cells (MDSCs) was investigated by co‐immunoprecipitation and Western blotting.

Results

We found that increased Tfh cells with IFN‐I–inducible gene signatures correlated with disease activities in patients with SLE. Consistently, IFN‐β treatment markedly enhanced Tfh cell response and exacerbated disease progression in lupus mice. Moreover, mice with IFNAR1 deficiency exhibited attenuated lupus progression with significantly decreased Tfh response. Mechanistically, IFN‐β activated the indoleamine 2,3‐dioxygenase/kynurenine/aryl hydrocarbon receptor (IDO/Kyn/AhR) axis to promote Tfh cell differentiation. Notably, expanded MDSCs in lupus were found to produce high levels of IFN‐β. Further studies showed that the autoantigen activated lymphocyte‐derived DNA stimulated IFN‐β production by MDSCs via the cyclic GMP‐AMP synthase–stimulator of IFN genes (cGAS‐STING)–dependent pathway.

Conclusion

These results have demonstrated a novel function of IFN‐β in promoting Tfh cell response during lupus progression, which may facilitate the identification of new therapeutic targets for the treatment of SLE. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicInterferon-betaT Follicular Helper CellsMyeloid-Derived Suppressor CellsAnimalsMiceFemaleHumansCell DifferentiationReceptor, Interferon alpha-betaDisease ProgressionMice, KnockoutReceptors, Aryl HydrocarbonMaleDisease Models, AnimalSignal Transduction

Substanzen

Interferon-betaReceptor, Interferon alpha-betaReceptors, Aryl HydrocarbonIfnar1 protein, mouse

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
  • Department of Pathology, Faculty of Medicine, The University of Hong Kong, Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, China.
  • Institute of Biology and Medical Sciences, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.
  • Department of Rheumatology, The Second People's Hospital of Three Gorges University, Yichang, China.

ORCID-Profile: Shengjun Wang, Liwei Lu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Rui, K., Chen, Z., Liu, J., Huang, W., Wang, X., Xiao, F., Zhou, Y., Dai, X., Tang, Y., Zhao, M., Peng, N., Wang, X., Zhu, B., Wang, S., Lu, L., & Tian, J. (2026). Myeloid‐Derived Suppressor Cell–Derived Interferon‐β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development. Arthritis & Rheumatology. https://doi.org/10.1002/art.70004

Vancouver

Rui K, Chen Z, Liu J, Huang W, Wang X, Xiao F, et al. Myeloid‐Derived Suppressor Cell–Derived Interferon‐β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development. Arthritis & Rheumatology. 2026. doi:10.1002/art.70004

BibTeX
@article{Rui2026,
  author = {Rui, Ke and Chen, Zixiang and Liu, Jun and Huang, Wei and Wang, Xiaomeng and Xiao, Fan and Zhou, Yingbo and Dai, Xiaoqiu and Tang, Yuan and Zhao, Mengna and Peng, Na and Wang, Xiaoran and Zhu, Bo and Wang, Shengjun and Lu, Liwei and Tian, Jie},
  title = {Myeloid‐Derived Suppressor Cell–Derived Interferon‐β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70004}
}
Kostenlos starten →